Immunohistochemical Expression of Preferentially Expressed Antigen in Melanoma (PRAME) in the Uninvolved Background Testis, Germ Cell Neoplasia in Situ, and Germ Cell Tumors of the Testis.
Costantino RicciTania FranceschiniFrancesca GiunchiMarco GrilliniFrancesca AmbrosiFrancesco MassariVeronica MollicaMaurizio ColecchiaMichelangelo FiorentinoPublished in: American journal of clinical pathology (2021)
PRAME is an additional marker for the differential diagnosis of GCTT and could play a key role in the transition from seminomatous to nonseminomatous GCTT.